Search

Search Constraints

You searched for: Author/Creator Katsila, Theodora

Search Results

1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Issue 10374 (4th February 2023)

2. Correlation of SIN3A genomic variants with β-hemoglobinopathies disease severity and hydroxyurea treatment efficacy. (November 2016)

5. Documentation of clinically relevant genomic biomarker allele frequencies in the next‐generation FINDbase worldwide database. Issue 6 (14th April 2020)

6. Functional Analysis of an Aγ-Globin Gene Promoter Variant (HBG1: g.-225_-222delAGCA) Underlines Its Role in Increasing Fetal Hemoglobin Levels Under Erythropoietic Stress. (2nd January 2016)

7. Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients. (March 2016)